Dr. Dusty Miller and previous postdoctoral fellow Dr. Sarah Wootton, members of the Divisions of Human Biology and Basic Sciences, developed a murine model of JSRV-associated lung cancer in which the JSRV envelope protein (Jenv) drives tumor formation when delivered intranasally via an adeno-associated virus vector. Research associate Dr. Andrew Vaughan used this model to inquire whether Jenv-induced tumors are maintained by a small number of cancer stem cells (CSC). Such cells have been implicated in the origin and maintenance of human cancers including NSCLC, breast, pancreas, prostate and cancers of the hematopoietic system. Ideally, therapies would be developed to selectively target CSC. This is the first reported study that investigates whether CSC also play a role in infection-associated cancers.
Vaughan and colleagues sorted Jenv-positive cells from mouse lung tumors based on the differential expression of previously identified cell markers of CSC (CD133, CD34 or Sca-I). These populations were then transplanted into immunocompromised mice via intranasal inhalation. The authors observed no difference in tumor burden or histology between mice that received cells expressing the putative CSC markers and cells with little to no expression of these markers. In addition, they did not find any lung cells that expressed the stem cell-associated transcription factor, Oct4, in mice with virally induced lung tumors. Therefore, the authors concluded that Jenv-induced tumors are not maintained by a small population of CSC. They also sorted cells with different levels of Wnt-signaling from a Jenv-positive mouse lung tumor cell line, as Wnt-signaling has been associated with bronchioalveolar stem cell maintenance. When cells with high or low Wnt-signaling were transplanted subcutaneously into the flanks of immunocompromised mice, a positive correlation was observed between the level of Wnt-signaling and the number and size of subcutaneous tumors. Interestingly, previous studies have shown that hyperactive Wnt-signaling is associated with human lung cancer metastasis, indicating that Wnt is a key player in several aspects of lung cancer.
Vaughan AE, Halbert CL, Wootton SK, Miller D. 2011. Lung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells, but tumorigenicity does correlate with Wnt pathway activation. Molecular Cancer Research, Epub ahead of print, doi: 10.1158/1541-7786.MCR-11-0285
Basic Sciences Division
Human Biology Division
Maggie Burhans, Ph.D.
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Research Division
Julian Simon, Ph.D.
Clinical Research Division
and Human Biology Division
Arnold Digital Library